The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5903729 6775567 I 5903729-9 20080828 20080908 20080930 PER US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2008-BP-14244BP B.I. PHARMACEUTICALS,INC./RIDGEFIELD M Y 20080930 CN

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5903729 1010521566 PS SPIRIVA 1 RESPIRATORY (INHALATION) 18MCG NOT REPORTED 021395
5903729 1010521567 C ALTACE 1 10MG
5903729 1010521568 C ASPIRIN 1 LOW DOSE

Indications of drugs used

Event ID DRUG SEQ INDI PT
5903729 1010521566 CHRONIC OBSTRUCTIVE PULMONARY DISEASE
5903729 1010521567 HYPERTENSION

Outcome of event

no results found

Reactions reported

Event ID PT
5903729 PROSTATIC SPECIFIC ANTIGEN INCREASED

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5903729 1010521566 20080801 20080801